Corpus Intelligence IC Memo — CITIZENS MEDICAL CENTER 2026-04-26 06:56 UTC
IC Memo — CITIZENS MEDICAL CENTER
Investment Committee Memorandum | KS | 23 beds | Grade C | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CITIZENS MEDICAL CENTER

CCN 171362 | THOMAS, KS | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CITIZENS MEDICAL CENTER is a 23-bed rural/critical access in THOMAS, KS with $49.5M in net patient revenue and a -13.9% operating margin. The hospital serves a payer mix of 72.1% Medicare, 1.7% Medicaid, and 26.3% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.9% to -6.6% (+736bps).

Net Revenue HCRIS$49.5M
Current EBITDA COMPUTED$-6.9M
Operating Margin COMPUTED-13.9%
Occupancy HCRIS45.3%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS44.3%
Distress Probability ML50.4%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
111
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -13.9% places it above the state median. Among 111 size-comparable peers (12-46 beds), the median margin is -20.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 111 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CITIZENS MEDICAL CENTER (Target)KS23$49.5M-13.9%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
KANSAS CITY ORTHOPAEDIC INSTITKS17$86.3M21.1%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SPINE & SPECIALTY HOSPIKS35$69.6M19.1%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%
VIA CHRISTI HOSP. WICHITA ST. KS38$55.1M16.7%
UKHS GREAT BEND CAMPUSKS29$53.8M-22.8%
NEOSHO MEMORIAL REGIONAL MED CKS21$53.8M-13.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$989K+200bp12mo
Denial Rate Reduction12.0%6.5%$979K+198bp12mo
A/R Days Reduction5200.0%3800.0%$602K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$989K
Denial Rate Reduction
$979K
A/R Days Reduction
$602K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.6M
Current EBITDA$-6.9M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$-3.2M
Current Margin-13.9%
Pro Forma Margin-6.6%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-10.6M$-9.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-10.6M$-13.4M0.00x-100.0%
Bull Case9.0x11.0x$-9.5M$-4.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-9.5M$-8.1M0.00x-100.0%
Bear Case11.0x10.0x$-11.7M$-23.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-11.7M$-30.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 72.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 50.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 111 hospitals with 12-46 beds
  • Same-state prioritization (n=112)
  • Comp margins: P25=-31.1% / P50=-20.7% / P75=-11.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.